Caveolin-1 and -2 regulate cell motility in castration-resistant prostate cancer

References

• SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
   PubMed Web of Science ®Google Scholar
• Cancer Registration Committee of the Japanese Urological Association Clinicopathological statistics on registered prostate cancer patients in JapanReport from the Japanese Urological AssociationInt J Urol20002005124661
   Google Scholar
• HinotsuSAkazaHUsamiMCurrent status of endocrine therapy for prostate cancer in Japan—analysis of primary androgen deprivation therapy on the basis of data collected by J-CaPJpn J Clin Oncol20073777578117965423
   PubMed Web of Science ®Google Scholar
• CooperbergMRHinotsuSNamikiMRisk assessment among prostate cancer patients receiving primary androgen deprivation therapyJ Clin Oncol200927264306431319667269
   PubMed Web of Science ®Google Scholar
• HotteSJSaadFCurrent management of castrate-resistant prostate cancerCurr Oncol201017Suppl 27279
   PubMed Web of Science ®Google Scholar
• FridolfssonHNRothDMInselPAPatelHHRegulation of intracellular signaling and function by caveolinFaseb J20142893823383124858278
   PubMed Web of Science ®Google Scholar
• GuptaRToufailyCAnnabiBCaveolin and cavin family members: dual roles in cancerBiochimie2014107Pt B18820225241255
   PubMed Web of Science ®Google Scholar
• SonninoSPrinettiASphingolipids and membrane environments for caveolinFEBS Lett2009583459760619167383
   PubMed Web of Science ®Google Scholar
• ChenDCheGValue of caveolin-1 in cancer progression and prognosis: Emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression (Review)Oncol Lett2014841409142125202343
   PubMed Web of Science ®Google Scholar
• BurgermeisterELiscovitchMRöckenCSchmidRMEbertMPCaveats of caveolin-1 in cancer progressionCancer Lett2008268218720118482795
   PubMed Web of Science ®Google Scholar
• AndoTIshiguroHKimuraMThe overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinomaOncol Rep200718360160917671707
   PubMed Web of Science ®Google Scholar
• SagaraYMimoriKYoshinagaKClinical significance of Caveo-lin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancerBr J Cancer200491595996515305200
   PubMed Web of Science ®Google Scholar
• NimriLBarakHGraeveLSchwartzBRestoration of caveolin-1 expression suppresses growth, membrane-type-4 metalloproteinase expression and metastasis-associated activities in colon cancer cellsMol Carcinog2013521185987022674854
   PubMed Web of Science ®Google Scholar
• DavidsonBNeslandJMGoldbergICaveolin-1 expression in advanced-stage ovarian carcinoma--a clinicopathologic studyGynecol Oncol200181216617111330944
   PubMed Web of Science ®Google Scholar
• WiechenKSersCAgoulnikADown-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomasAm J Pathol2001158383383911238032
   PubMed Web of Science ®Google Scholar
• KaruppiahKDruhanLJChenCASuppression of eNOS-derived superoxide by caveolin-1: a biopterin-dependent mechanismAm J Physiol Heart Circ Physiol20113013H903H91121724868
   PubMed Web of Science ®Google Scholar
• SugieSMukaiSYamasakiKKamibeppuTTsukinoHKamotoTSignificant association of caveolin-1 and caveolin-2 with prostate cancer progressionCancer Genomics Proteomics201512639139626543085
   PubMed Web of Science ®Google Scholar
• YangGGoltsovAARenCCaveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancerMol Cancer Res201210221822922144662
   PubMed Web of Science ®Google Scholar
• WilliamsTMHassanGSLiJCaveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp miceJ Biol Chem200528026251342514515802273
   PubMed Web of Science ®Google Scholar
• SugieSMukaiSTsukinoHIncreased plasma caveolin-1 levels are associated with progression of prostate cancer among Japanese menAnticancer Res20133351893189723645736
   PubMed Web of Science ®Google Scholar
• SuzuokiMMiyamotoMKatoKImpact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinomaBr J Cancer200287101140114412402154
   PubMed Web of Science ®Google Scholar
• ChatterjeeMBen-JosefEThomasDGcaveolin-1 is associated with tumor progression and confers a multi-modality resistance phenotype in pancreatic cancerSci Rep20155121086726065715
   PubMed Web of Science ®Google Scholar
• BenderFCReymondMABronCQuestAFCaveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicityCancer Res200060205870587811059785
   PubMed Web of Science ®Google Scholar
• van den EyndenGGvan LaereSJvan der AuweraIOverexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancerBreast Cancer Res Treat200695321922816244790
   PubMed Web of Science ®Google Scholar
• KatoKHidaYMiyamotoMOverexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stageCancer200294492993311920460
   PubMed Web of Science ®Google Scholar
• AndoTIshiguroHKimuraMThe overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinomaOncol Rep200718360160917671707
   PubMed Web of Science ®Google Scholar
• HuYCLamKYLawSWongJSrivastavaGProfiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCCClin Cancer Res20017113519352511705871
   PubMed Web of Science ®Google Scholar
• FongAGarciaEGwynnLLisantiMPFazzariMJLiMExpression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiationAm J Clin Pathol200312019310012866378
   PubMed Web of Science ®Google Scholar
• YuanGRegelILianFWNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cellsOncogene201332337538722370641
   PubMed Web of Science ®Google Scholar
• LiMChenHDiaoLZhangYXiaCYangFCaveolin-1 and VEGF-C promote lymph node metastasis in the absence of intratumoral lymphangiogenesis in non-small cell lung cancerTumori201096573474321302621
   PubMed Web of Science ®Google Scholar
• NasuYTimmeTLYangGSuppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cellsNat Med199849106210649734401
   PubMed Web of Science ®Google Scholar
• ChengHFukushimaTTakahashiNTanakaHKataokaHHepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinasesCancer Res20096951828183519223533
   PubMed Web of Science ®Google Scholar
• ZhangXLingMTWangQIdentification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cellsJ Biol Chem200728246332843329417855368
   PubMed Web of Science ®Google Scholar
• LiangWHaoZHanJLZhuDJJinZFXieWLCAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transitionUrol Oncol201432685586324968949
   PubMed Web of Science ®Google Scholar
• MeyerCDzieranJLiuYDistinct dedifferentiation processes affect caveolin-1 expression in hepatocytesCell Commun Signal2013111623339737
   PubMed Web of Science ®Google Scholar
• HuangCQiuZWangLA novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasisCancer Res201272365566522194465
   PubMed Web of Science ®Google Scholar
• ZhangJZhangKZhouLExpression and potential correlation among Forkhead box protein M1, Caveolin-1 and E-cadherin in colorectal cancerOncol Lett20161242381238827698803
   PubMed Web of Science ®Google Scholar
• SatelliALiSVimentin as a potential molecular target in cancer therapy Or Vimentin, an overview and its potential as a molecular target for cancer therapyCell Mol Life Sci201168183033304621637948
   PubMed Web of Science ®Google Scholar
• XuZBianHZhangFURI promotes the migration and invasion of human cervical cancer cells potentially via upregulation of vimentin expressionAm J Transl Res201796303728670391
   PubMed Web of Science ®Google Scholar
• WangXHeHZhangHClinical and prognostic implications of β1, 6-N-acetylglucosaminyltransferase V in patients with gastric cancerCancer Sci2013104218519323107376
   PubMed Web of Science ®Google Scholar
• GranovskyMFataJPawlingJMullerWJKhokhaRDennisJWSuppression of tumor growth and metastasis in Mgat5-deficient miceNat Med20006330631210700233
   PubMed Web of Science ®Google Scholar
• OsakoYSekiNKitaYRegulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinomaInt J Oncol20164962255226427779648
   PubMed Web of Science ®Google Scholar
• SchickMHabringerSNilssonJAKellerUPathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancersBr J Haematol2017179572473829171017
   PubMed Web of Science ®Google Scholar
• KalkatMde MeloJHickmanKAMYC Deregulation in Primary Human CancersGenes201786151
   PubMed Web of Science ®Google Scholar
• KatoFFiorentinoFPAlibésAMYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cellsOncotarget201774777378
   Google Scholar
• TyagiNDeshmukhSKSrivastavaSKETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1Mol Cancer Res201816218719629117940
   PubMed Web of Science ®Google Scholar
• WangSDingZFibroblast growth factor receptors in breast cancerTumor Biol20173951010428317698370
   Google Scholar
• AnbalaganMMorozKAliACarrierLGlodowskiSRowanBGSubcellular localization of total and activated Src kinase in African American and Caucasian breast cancerPLoS One201273e3301722457730
   PubMed Web of Science ®Google Scholar
• SunYWangBELeongKGAndrogen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapyCancer Res201272252753622108827
   PubMed Web of Science ®Google Scholar
• ielSVasseurCBruyereFRozetFMaheoKFromontGClinical significance of epithelial-mesenchymal transition markers in prostate cancerHum Pathol201761263227818287
   PubMed Web of Science ®Google Scholar